Are major risk factors for myocardial infarction the major predictors of degree of coronary artery disease in men?

Metabolism: Clinical and Experimental

Volumn 53, Issue 3, 2004, Pages 324-329

  Phillips, Gerald B ^a,b   Pinkernell, Bruce H ^a   Jing, Tian Yi ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TESTOSTERONE;

ADULT; AGE; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OBESITY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; TESTOSTERONE BLOOD LEVEL; UNITED STATES; AGED; BLOOD; CORONARY ARTERY ATHEROSCLEROSIS; MIDDLE AGED; PATHOPHYSIOLOGY;

AGE FACTORS; AGED; AGED, 80 AND OVER; CHOLESTEROL, HDL; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DIABETES COMPLICATIONS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; RISK FACTORS; SMOKING; TESTOSTERONE;

EID: 1842506377     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2003.11.008     Document Type: Article

References (46)

1. Swanson JO, Pierpont G, Adicoff A: Serum high density lipoprotein cholesterol correlates with presence but not severity of coronary artery disease. Am J Med 71:235-239, 1981
2. Schmidt SB, Wasserman AG, Muesing RA, et al: Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis. Am J Cardiol 55:1459-1462, 1985
3. Sedlis SP, Schechtman KB, Ludbrook PA, et al: Plasma apoproteins and the severity of coronary artery disease. Circulation 73:978-986, 1986
4. Goldberg RJ, Gore JM, Zive M, et al: Serum estradiol and coronary artery disease. Am J Med 82:1-4, 1987
5. Bovet P, Darioli R, Essinger A, et al: Phospholipids and other lipids in angiographically assessed coronary artery disease. Atherosclerosis 80:41-47, 1989
6. Reinhart RA, Gani K, Arndt MR, et al: Apolipoproteins A-I and B as predictors of angiographically defined coronary artery disease. Arch Intern Med 150:1629-1633, 1990
7. Negri M, Sheiban I, Arigliano PL, et al: Interrelation between angiographic severity of coronary artery disease and plasma levels of insulin, c-peptide and plasminogen activator inhibitor-1. Am J Cardiol 72:397-401, 1993
8. Kimbiris D, Lavine P, van den Broek H, et al: Devolutionary pattern of coronary atherosclerosis in patients with angina pectoris. Am J Cardiol 33:7-11, 1974
9. McLaughlin PR, Berman ND, Morton BC, et al: Long-term angiographic assessment of the influence of coronary risk factors on native coronary circulation and saphenous vein aortocoronary grafts. Am Heart J 93:327-333, 1977
10. Kramer JR, Matsuda Y, Mulligan JC, et al: Progression of coronary atherosclerosis. Circulation 63:519-526, 1981
11. Shub C, Vlietstra RE, Smith HC, et al: The unpredictable progression of symptomatic coronary artery disease. Mayo Clin Proc 56:155-160, 1981
12. Kramer JR, Kitazume H, Proudfit WL, et al: Progression and regression of coronary atherosclerosis: Relation to risk factors. Am Heart J 105:134-144, 1983
13. Phillips GB, Pinkernell BH, Jing TY: The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 14:701-706, 1994
14. Kannel WB: Blood pressure as a cardiovascular risk factor. Prevention and treatment. JAMA 275:1571-1576, 1996
15. Summary of the Second Report of the National Cholesterol Education Program (NCEP): Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 269:3015-3023, 1993
16. Lamon-Fava S, Wilson PWF, Schaefer EJ: Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 16:1509-1515, 1996
17. Judkins MP: Selective coronary arteriography, part I: A percutaneous transfemoral technic. Radiology 89:815-824, 1967
18. Sodergard R, Backstrom T, Shanbhag V, et al: Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature. J Steroid Biochem 16:801-810, 1982
19. Stoffer SS, Hynes KM, Jiang N-S, et al: Digoxin and abnormal serum hormone levels. JAMA 225:1643-1644, 1973
20. Tappler B, Katz M: Pituitary-gonadal dysfunction in low-output cardiac failure. Clin Endocrinol 10:219-226, 1979
21. Vlietstra RE, Kronmal RA, Frye RL, et al: Factors affecting the extent and severity of coronary artery disease in patients enrolled in the coronary artery surgery study. Arteriosclerosis 2:208-215, 1982
22. Hak AE, Witteman JCM, de Jong FH, et al: Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: The Rotterdam study. J Clin Endocrinol Metab 87:3632-3639, 2002
23. De Pergola G, Pannacciulli N, Ciccone M, et al: Free testosterone plasma levels are negatively associated with the intima-media thickness of the common carotid artery in overweight and obese glucose-tolerant young adult men. Intern J Obes 27:803-807, 2003
24. UKPDS Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
25. Ando S, Rubens R, Rottiers R: Androgen plasma levels in male diabetics. J Endocrinol Invest 7:21-24, 1984
26. Small M, MacRury S, Beastall GH, et al: Oestradiol levels in diabetic men with and without a previous myocardial infarction. QJM 243:617-623, 1987
27. Barrett-Connor E, Khaw K-T, Yen SSC: Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol 132:895-901, 1990
28. Pyorala K, Laakso M, Uusitupa M: Diabetes and atherosclerosis: An epidemiologic view. Diabetes Metab Rev 3:463-524, 1987
29. Haffner SM, Shaten J, Stern MP, et al: Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. Am J Epidemiol 143: 889-897, 1996
30. Oh J-Y, Barrett-Connor E, Wedick NM, et al: Endogenous sex hormones and the development of type 2 diabetes in older men and women: The Rancho Bernardo Study. Diabetes Care 25:55-60, 2002
31. Levine GN, Keaney JF Jr, Vita JA: Cholesterol reduction in cardiovascular disease. N Engl J Med 332:512-521, 1995
32. Waters D, Higginson L, Gladstone P, et al: Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Atherosclerosis Intervention Trial. Circulation 89: 959-968, 1994
33. Jukema JW, Bruschke AVG, van Boven AdJ, et al: Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 91:2528-2540, 1995
34. Pitt B, Mancini GBJ, Ellis SG, et al: Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events. J Am Coll Cardiol 26:1133-1139, 1995
35. Sacks FM, Gibson M, Rosner B, et al: The influence of pretreatment low density lipoprotein cholesterol concentrations on the effect of hypocholesterolemic therapy on coronary atherosclerosis in angiographic trials. Am J Cardiol 76:78C-85C, 1995
36. Sacks FM, Pasternak RC, Gibson CM, et al: Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients. Lancet 344:1182-1186, 1994
37. Rosenson RS, Tangney CC: Antiatherothrombotic properties of statins. JAMA 279:1643-1650, 1998
38. Jialal I, Stein D, Balis D, et al: Effect of hydroxymethyl glutaryl coenzyme A reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation 103:1933-1935, 2001
39. Sprecher DL, Schaefer EJ, Kent KM, et al: Cardiovascular features of homozygous familial hypercholesterolemia: Analysis of 16 patients. Am J Cardiol 54:20-30, 1984
40. Phillips GB: Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity. Metabolism 42:116-120, 1993
41. Marin P, Holmang S, Jonsson L, et al: The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes 16:991-997, 1992
42. Cooper LT, Cooke JP, Dzau VJ: The vasculopathy of aging. J Gerontol 49:B191-B196, 1994
43. Chang E, Harley CB: Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 92:11190-11194, 1995
44. Dansky HM, Fisher EA: High-density lipoprotein and plaque regression. The good cholesterol gets even better. Circulation 100: 1762-1763, 1999
45. Alexandersen P, Haarbo J, Byrjalsen I, et al: Natural androgens inhibit male atherosclerosis. A study in castrated, cholesterol-fed rabbits. Circ Res 84:813-819, 1999
46. Bruck B, Brehme U, Gugel N, et al: Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits. Arterioscl Thromb Vasc Biol 17:2192-2199, 1997